Astellas Pharma, Inc. (ALPMF)
15.35
+0.10
(+0.66%)
USD |
OTCM |
Oct 06, 16:00
Astellas Pharma Price to Book Value : 2.303 for Oct. 6, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| October 06, 2026 | 2.303 |
| October 05, 2026 | 2.288 |
| October 02, 2026 | 2.156 |
| October 01, 2026 | 2.201 |
| September 30, 2026 | 2.201 |
| September 29, 2026 | 2.370 |
| September 28, 2026 | 2.453 |
| September 25, 2026 | 2.284 |
| September 24, 2026 | 2.258 |
| September 23, 2026 | 2.390 |
| September 22, 2026 | 2.297 |
| September 21, 2026 | 2.288 |
| September 18, 2026 | 2.078 |
| September 17, 2026 | 2.078 |
| September 16, 2026 | 2.078 |
| September 15, 2026 | 2.400 |
| September 14, 2026 | 2.340 |
| September 11, 2026 | 2.378 |
| September 10, 2026 | 2.318 |
| September 09, 2026 | 2.348 |
| September 08, 2026 | 2.370 |
| September 04, 2026 | 2.265 |
| September 03, 2026 | 2.222 |
| September 02, 2026 | 2.222 |
| September 01, 2026 | 2.222 |
| Date | Value |
|---|---|
| August 31, 2026 | 2.385 |
| August 28, 2026 | 2.265 |
| August 27, 2026 | 2.475 |
| August 26, 2026 | 2.10 |
| August 25, 2026 | 2.378 |
| August 24, 2026 | 2.378 |
| August 21, 2026 | 2.438 |
| August 20, 2026 | 2.468 |
| August 19, 2026 | 2.280 |
| August 18, 2026 | 2.280 |
| August 17, 2026 | 2.370 |
| August 14, 2026 | 2.423 |
| August 13, 2026 | 2.018 |
| August 12, 2026 | 2.408 |
| August 11, 2026 | 2.408 |
| August 10, 2026 | 2.235 |
| August 07, 2026 | 2.408 |
| August 06, 2026 | 1.958 |
| August 05, 2026 | 1.928 |
| August 04, 2026 | 1.928 |
| August 03, 2026 | 2.066 |
| July 31, 2026 | 2.213 |
| July 30, 2026 | 2.303 |
| July 29, 2026 | 2.303 |
| July 28, 2026 | 2.153 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Takeda Pharmaceutical Co., Ltd. | 1.230 |
| Daiichi Sankyo Co., Ltd. | 3.032 |
| Eisai Co., Ltd. | 1.481 |
| Chugai Pharmaceutical Co., Ltd. | 5.085 |
| Santen Pharmaceutical Co., Ltd. | 1.778 |
Price to Book Value Related Metrics
| PE Ratio | 11.71 |
| PS Ratio | 1.875 |
| PEG Ratio | 0.0367 |
| Price to Free Cash Flow | 9.266 |
| Price | 15.35 |
| Earnings Yield | 8.54% |
| Market Cap | 27.52B |
| PEGY Ratio | 0.0364 |
| Operating PE Ratio | 8.618 |
| Normalized PE Ratio | 11.71 |